Desensitization with antigen-specific immunoadsorption interferes with complement in ABO-incompatible kidney transplantation
BACKGROUND: Complement activation was characterized during and after desensitization treatment in 19 consecutive patients receiving ABO-incompatible (ABOi) living donor kidney transplants to assess the effect of desensitization protocol including antigen-specific immunoadsorption (IA) on complement activation.METHODS: All patients received rituximab- and tacrolimus-based triple treatment. Anti-A/B
